S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Black landowner digs in against land grab for oil pipeline
Opponents suspect environmental racism in pipeline project
GOP pushes bills to allow social media 'censorship' lawsuits
Russia scores points with vaccine diplomacy, but snags arise
North Macedonia gets first batch of Russia vaccine Sputnik V
Australia ends defense cooperation with Myanmar over coup
Asian shares mixed after US stimulus bill, profit-taking
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Black landowner digs in against land grab for oil pipeline
Opponents suspect environmental racism in pipeline project
GOP pushes bills to allow social media 'censorship' lawsuits
Russia scores points with vaccine diplomacy, but snags arise
North Macedonia gets first batch of Russia vaccine Sputnik V
Australia ends defense cooperation with Myanmar over coup
Asian shares mixed after US stimulus bill, profit-taking
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Black landowner digs in against land grab for oil pipeline
Opponents suspect environmental racism in pipeline project
GOP pushes bills to allow social media 'censorship' lawsuits
Russia scores points with vaccine diplomacy, but snags arise
North Macedonia gets first batch of Russia vaccine Sputnik V
Australia ends defense cooperation with Myanmar over coup
Asian shares mixed after US stimulus bill, profit-taking
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Black landowner digs in against land grab for oil pipeline
Opponents suspect environmental racism in pipeline project
GOP pushes bills to allow social media 'censorship' lawsuits
Russia scores points with vaccine diplomacy, but snags arise
North Macedonia gets first batch of Russia vaccine Sputnik V
Australia ends defense cooperation with Myanmar over coup
Asian shares mixed after US stimulus bill, profit-taking
Log in
CVE:MDP

Medexus Pharmaceuticals Earnings Date, Estimates & History

C$6.80
-0.22 (-3.13 %)
(As of 03/5/2021 03:59 PM ET)
Add
Compare
Today's Range
C$6.55
Now: C$6.80▼
C$7.38
50-Day Range
C$6.96
MA: C$7.99▼
C$9.70
52-Week Range
C$1.42
Now: C$6.80▼
C$9.75
Volume91,729 shs
Average Volume90,818 shs
Market CapitalizationC$129.82 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Earnings

Medexus Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, June 28th, 2021 based off prior year's report dates.

Medexus Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Medexus Pharmaceuticals (CVE:MDP) Earnings Estimates

2021 EPS Consensus Estimate: $0.16
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20211($0.03)($0.03)($0.03)
Q2 20211$0.04$0.04$0.04
Q3 20211$0.14$0.14$0.14
Q4 20211$0.01$0.01$0.01

Medexus Pharmaceuticals (CVE MDP) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
6/28/2021
(Estimated)		       
11/16/2020Q2 2021C$0.08C($0.13)C($0.13)C$29.40 millionC$23.63 millionN/A
8/11/2020Q1 2021C($0.09)C($0.31)C($0.31)C$27.20 millionC$27.52 millionN/A
6/22/2020Q4 2020C($0.30)C($0.13)C($0.13)C$15.60 millionC$25.63 millionN/A
2/18/2020Q3 2020C($0.17)C($0.17)C$16.20 millionN/A
11/29/2019Q2 2020C($0.03)C$0.05C$0.05C$17.95 millionC$16.40 millionN/A
8/22/2019Q1 2020C($0.13)C($0.15)C($0.15)C$15.87 millionC$16.13 millionN/A
7/8/2019Q4 2019C($0.02)C($0.02)C$12.75 millionN/A
2/25/2019Q3 2019C($0.02)C($0.02)C$0.06C$12.50 millionC$14.42 millionN/A
8/27/2018Q1 2019C($0.15)C($0.15)C$3.25 millionN/A
7/18/2018Q4 2018C($0.15)C($0.15)C$2.10 millionN/A
2/27/2018Q3 2018C($0.15)C($0.15)C($0.15)C$2.60 millionC$2.36 millionN/A
8/24/2017Q1 2018C($0.15)C($0.15)C($0.15)C$2.00 millionC$2.47 millionN/A
6/28/2017Q4 2017C($0.30)C($0.30)C($0.30)C$1.50 millionC$1.66 millionN/A
2/28/2017Q3 2017C($0.15)C($0.15)C($0.15)C$1.77 millionN/A
11/28/2016Q2 2017C($0.15)C($0.15)C$1.88 millionN/A
8/18/2016Q1 2017C$0.30C$0.30C$0.89 millionN/A
6/27/2016Q4 2016C($0.30)C($0.30)C$0.65 millionN/A
2/25/2016Q3 2016C($0.30)C($0.30)C$1.02 millionN/A
11/30/2015Q2 2016C($0.15)C($0.15)C$1.47 millionN/A
8/27/2015Q1 2016C($0.30)C($0.30)C$0.61 millionN/A
7/20/2015Q4 2015C($0.45)C($0.45)C$0.34 millionN/A
3/2/2015Q3 2015C($0.30)C($0.30)C$0.92 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/8/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.